Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
---|
06/03/2004 | WO2004046137A1 New tricyclic angiotensin ii agonists |
06/03/2004 | WO2004046130A1 Pyridazinone derivatives as cdk2-inhibitors |
06/03/2004 | WO2004046119A1 Substituted aralkyl derivatives |
06/03/2004 | WO2004046117A1 Pyridazinone derivatives as gsk-3beta inhibitors |
06/03/2004 | WO2004046115A1 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors |
06/03/2004 | WO2004046095A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication |
06/03/2004 | WO2004037248A3 Modulation of peroxisome proliferator activated receptors activity |
06/03/2004 | WO2004027046A3 Methods of producing 4-amino-3-mercapto-triazoles |
06/03/2004 | WO2004022542A3 Substituted 1,2,3,4-tetrahydroquinoline derivatives |
06/03/2004 | WO2004018419A3 Benzimidazole quinolinones and uses thereof |
06/03/2004 | WO2004009549A3 Piperidines useful for the treatment of central nervous system disorders |
06/03/2004 | WO2003051842A3 Compositions decreasing activity of hormone-sensitive lipase |
06/03/2004 | US20040106805 optionally oxa-, thia- or hydrocarbylaza-substituted pentalenones, e.g., 3aR, 6aR) 4-tert-Butyl-N-[2-(4-hydroxyphenyl)-1S-(3-oxo-hexahydrocyclopenta[b]furan-3a-ylcChagas' diseasearbamoyl)-ethyl]benzamide; treating Chagas' disease |
06/03/2004 | US20040106800 cannabinoid (cb1); treating disorders involving cannabinoid neurotransmission |
06/03/2004 | US20040106794 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
06/03/2004 | US20040106792 Biphenyl compound |
06/03/2004 | US20040106676 Water-soluble etoposide analogs and methods of use thereof |
06/03/2004 | US20040106667 novel specific indazoles exhibiting anticancer activity via the modulation of the activity of proteins, in particular of kinases |
06/03/2004 | US20040106659 hydantoin, oxazoledione and thiazoledione (or dithiione) derivatives; e.g., 5-[1-(Biphenyl-4-yloxy)-ethyl]-5-methyl-imidazolidine-2,4-dione |
06/03/2004 | US20040106645 Antagonists of melanin concentrating hormone receptor |
06/03/2004 | US20040106634 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK |
06/03/2004 | US20040106633 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors |
06/03/2004 | US20040106627 Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors |
06/03/2004 | US20040106626 amidine containing compounds which inhibit serine proteases |
06/03/2004 | US20040106616 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity |
06/03/2004 | US20040106615 For treating or lessening the severity of a variety of disorders, including stroke, inflammatory disorders, autoimmune diseases such as SLE lupus and psoriasis, proliferative disorders such as cancer, and conditions associated with organ transplant |
06/03/2004 | US20040106606 Dihydropyrones with tethered heterocycles |
06/03/2004 | US20040106599 an aromatic or heteroaromatic amide compound useful as antiproliferative agent |
06/03/2004 | US20040106521 Pyrrolecarboxamides and pyrrolethioamides as fungicides |
06/03/2004 | US20040106519 Herbicidal composition |
06/03/2004 | DE10254336A1 Carbonsäureamide Carboxamides |
06/03/2004 | DE10254092A1 New pyrimidine-4,6-dicarboxamide derivatives, are selective collagenase inhibitors useful e.g. for treating degenerative joint diseases, connective tissue disorders or cancer |
06/03/2004 | CA2518917A1 Pyridazinone derivatives as cdk2-inhibitors |
06/03/2004 | CA2506415A1 Substituted aryl thioureas and releated compounds; inhibitors of viral replication |
06/03/2004 | CA2506112A1 Substituted aralkyl derivatives |
06/03/2004 | CA2506022A1 Pyridazinone derivatives as gsk-3beta inhibitors |
06/02/2004 | EP1423393A1 Cyclic indole and heteroindole derivatives, the production and use thereof as medicaments |
06/02/2004 | EP1423387A1 Photochromic bis-naphthopyran compounds and methods for their manufacture |
06/02/2004 | EP1423386A1 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors |
06/02/2004 | EP1423381A1 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
06/02/2004 | EP1423366A1 Cyclopenta b ! indole derivatives as spla2 inhibitors |
06/02/2004 | EP1423110A2 Cbi analogues of cc-1065 and the duocarmycins |
06/02/2004 | EP1423100A1 Plaster for the treatment of dysfunctions and disorders of nails, comprising sertaconazole |
06/02/2004 | EP1423004A1 Herbicidal n-alkylsulfonamino derivatives |
06/02/2004 | CN1501917A Compounds useful as insecticides, compounds useful as acaricides, and processes to use and make same |
06/02/2004 | CN1152032C Pyridyl alkene- and pyridyl alkine-acid amides as cytostatics and immunosuppressives |
06/02/2004 | CN1152022C Alpha-substituted. pyrimidine-thioalkyl and alkyl ether compounds |
06/02/2004 | CN1152020C Benzimidazolrone and analogues, and uses as progesterone ligand thereof |
06/02/2004 | CN1152015C Piperazine devivatives and preparing method thereof |
06/02/2004 | CN1152014C N-aryl anthranilic acid derivatives and uses thereof |
06/02/2004 | CN1151789C Use of aryl (or heteroaryl) pyrrolyl methanol derivatives |
06/01/2004 | US6743815 Estrogen receptor modulators |
06/01/2004 | US6743810 Indol-3-yl derivatives |
06/01/2004 | US6743809 Indole Derivatives useful for the treatment of CNS disorders |
06/01/2004 | US6743808 4-aryl-1-(indanmethyl, dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl) tetrahydropyridines or piperazines |
06/01/2004 | US6743807 Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α |
06/01/2004 | US6743804 Quinoline derivatives as NK3 antagonists |
06/01/2004 | US6743793 Dp receptor antagonist; prostaglandin d |
06/01/2004 | US6743788 Carbamate and oxamide compounds |
05/27/2004 | WO2004043983A1 4-methyl-2-oxo-2h-1-benzopyran-7yl 5-thio-beta-d-xylopyranoside derivative, method for preparing same and pharmaceutical composition containing same |
05/27/2004 | WO2004043952A1 Novel 2,3-dihydro-4(1h)-pyridinone derivatives, method for production thereof and pharmaceutical composition comprising the same |
05/27/2004 | WO2004043951A1 Pyrazole derivatives as modulators of peroxisome proliferator activated receptors |
05/27/2004 | WO2004043950A1 Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
05/27/2004 | WO2004043948A1 Sulfonamides |
05/27/2004 | WO2004043943A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
05/27/2004 | WO2004043936A1 Plk inhibitors |
05/27/2004 | WO2004043917A1 Sulfonamides |
05/27/2004 | WO2004043463A2 Sulfonamides |
05/27/2004 | WO2004043458A1 Bicyclic-substituted amines as histamine-3 receptor ligands |
05/27/2004 | WO2004043389A2 Methods of treating cancer and related methods |
05/27/2004 | WO2004043379A2 Chemical compounds |
05/27/2004 | WO2004043368A2 Sulfonamides |
05/27/2004 | WO2004043366A2 Sulfonamides |
05/27/2004 | WO2004032908A9 Method of inhibiting angiogenesis |
05/27/2004 | WO2003099812A8 Phenyl-furan or phenyl-thiophene derivatives, their preparation and their use as medicine |
05/27/2004 | WO2003088908A3 Heterocyclo inhibitors of potassium channel function |
05/27/2004 | WO2003039549A3 Selective antibacterial agents |
05/27/2004 | WO2003031436A8 Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
05/27/2004 | WO2003024961A8 Insecticidal 3-(2,6-disubstituted phenyl)-5-[4- or 5-arylthien-2- or -3-yl]-1,2,4-triazoles |
05/27/2004 | WO2003016276A3 3-substituted oxindole beta-3 agonists |
05/27/2004 | US20040102633 For therapy and prophylaxis of chronic obstructive pulmonary disease (COPD), asthma, airway hyper- reactivity, cough; inflammatory diseases such as inflammatory bowel disease, psoriasis, fibrositis, osteoarthritis |
05/27/2004 | US20040102630 For therapy of cancer, auto-immune diseases, cardiovascular diseases, infectious diseases, nephrological diseases, neurodegenerative diseases and viral infections |
05/27/2004 | US20040102609 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors |
05/27/2004 | US20040102592 As monomer to produce acrylic polymer |
05/27/2004 | US20040102508 Naphathalene derivatives which bind to the ep4 receptor |
05/27/2004 | US20040102507 Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
05/27/2004 | US20040102500 Peroxisome proliferator activated receptor alpha agonists |
05/27/2004 | US20040102498 Estrogen receptor modulators |
05/27/2004 | US20040102488 Antiinflamamtory agents; autoimmune diseases; antiarthritic agents; anticancer agents; Alzheimer's disease |
05/27/2004 | US20040102484 Prodrugs of proton pump inhibitors |
05/27/2004 | US20040102479 Novel benzopyran or thiobenzopyran derivatives |
05/27/2004 | US20040102474 Dietetics; antidiabetic agents; eating disorders |
05/27/2004 | US20040102464 Hypotensive agents; cardiovascular disorders; anticancer agents; headaches; antihistamines; antiinflamamtory agents |
05/27/2004 | US20040102455 Autoimmune diseases; antiinflammatory agents; antiallergens; viricides; anticancer agents |
05/27/2004 | US20040102450 Substituted oxoazaheterocyclyl compounds |
05/27/2004 | US20040102449 Pyridinyl, pyrimidinyl and pyrazinyl amides as potassium channel openers |
05/27/2004 | US20040102448 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
05/27/2004 | US20040102436 Heterocyclic compound derivatives and medicines |
05/27/2004 | US20040102432 Asthma, rhinitis therapy |
05/27/2004 | US20040102431 Protease inhibitors |